Glioma survival prediction with combined analysis of in vivo 11C-MET PET features, ex vivo features, and patient features by supervised machine learning

L Papp, N Pötsch, M Grahovac… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Gliomas are the most common type of tumor in the brain. Although the definite diagnosis is
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …

18F-FDOPA PET for the noninvasive prediction of glioma molecular parameters: a radiomics study

T Zaragori, J Oster, V Roch, G Hossu… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The assessment of gliomas by 18F-FDOPA PET imaging as an adjunct to MRI showed high
performance by combining static and dynamic features to noninvasively predict the isocitrate …

Feasibility on the use of radiomics features of 11 [C]-MET PET/CT in central nervous system tumours: Preliminary results on potential grading discrimination using a …

G Russo, A Stefano, P Alongi, A Comelli, B Catalfamo… - Current …, 2021 - mdpi.com
Background/Aim: Nowadays, Machine Learning (ML) algorithms have demonstrated
remarkable progress in image-recognition tasks and could be useful for the new concept of …

Feature-based PET/MRI radiomics in patients with brain tumors

P Lohmann, AK Meißner, M Kocher… - Neuro-oncology …, 2020 - academic.oup.com
Radiomics allows the extraction of quantitative features from medical images such as CT,
MRI, or PET, thereby providing additional, potentially relevant diagnostic information for …

Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma

M Lundemann, P Munck af Rosenschöld… - European journal of …, 2019 - Springer
Background Recurrence in glioblastoma patients often occur close to the original tumour
and indicates that the current treatment is inadequate for local tumour control. In this study …

Prediction of MGMT status for glioblastoma patients using radiomics feature extraction from 18F-DOPA-PET imaging

J Qian, MG Herman, DH Brinkmann, NN Laack… - International Journal of …, 2020 - Elsevier
Purpose Methylation of the O 6-methylguanine methyltransferase (MGMT) gene promoter is
associated with improved treatment response and survival in patients with glioblastoma …

Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas

G Ninatti, M Sollini, B Bono, N Gozzi, D Fedorov… - Neuro …, 2022 - academic.oup.com
Background PET with radiolabeled amino acids is used in the preoperative evaluation of
patients with glial neoplasms. This study aimed to assess the role of [11C] methionine (MET) …

Application of PET imaging delta radiomics for predicting progression-free survival in rare high-grade glioma

S Ahrari, T Zaragori, A Zinsz, J Oster, L Imbert… - Scientific Reports, 2024 - nature.com
This study assesses the feasibility of using a sample-efficient model to investigate radiomics
changes over time for predicting progression-free survival in rare diseases. Eighteen high …

Relevance of Dynamic 18F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes

S Ahrari, T Zaragori, L Rozenblum, J Oster, L Imbert… - Biomedicines, 2021 - mdpi.com
This study evaluates the relevance of 18F-DOPA PET static and dynamic radiomics for
differentiation of high-grade glioma (HGG) progression from treatment-related changes …

Fully automated analysis combining [18F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of …

KJ Paprottka, S Kleiner, C Preibisch, F Kofler… - European journal of …, 2021 - Springer
Purpose To evaluate diagnostic accuracy of fully automated analysis of multimodal imaging
data using [18F]-FET-PET and MRI (including amide proton transfer-weighted (APTw) …